Condensed Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020	[1]
Current assets
Cash	$ 12,264,285	$ 54,796
Prepaid expenses and other current assets	955,057	18,273
Total current assets	13,219,342	73,069
Deferred financing costs		392,337
Total assets	13,219,342	465,406
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Accounts payable and accrued expenses	2,589,520	3,115,924
Notes payable	50,510	543,990
Total current liabilities	2,640,030	3,659,914
Notes payable, net of current portion	21,590	21,590
Related party notes payable	1,000,000	1,000,000
Total long-term liabilities	1,021,590	1,021,590
Total liabilities	3,661,620	4,681,504
Commitments and contingencies
Stockholders’ equity (deficit)
Preferred stock, par value $0.00001, 10,000,000 shares authorized, no shares issued and outstanding
Common stock, $0.00001 par value; 100,000,000 shares authorized, 4,945,153 shares issued and outstanding as of March 31, 2021; 3,145,153 shares issued and outstanding as of December 31, 2020	49	31
Additional paid-in capital	22,584,788	6,431,715
Accumulated deficit	(13,027,115)	(10,647,844)
Total stockholders’ equity (deficit)	9,557,722	(4,216,098)
Total liabilities and stockholders’ equity (deficit)	$ 13,219,342	$ 465,406

[1] Derived from audited financial statements